University Hospitals Birmingham NHS Foundation Trust - New Queen Elizabeth Hospital
Welcome,         Profile    Billing    Logout  
 4 Trials 
3 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Welsh, Liam
CLINGLIO, NCT04250922 / 2018-000365-37: LAM561 With RT and TMZ for Adults With Glioblastoma

Active, not recruiting
2/3
140
Europe, RoW
LAM561, TMZ, RT
Laminar Pharmaceuticals, Laboratory Corporation of America, Northern Institute for Cancer Research, Newcastle, Theradis pharma, LIPODOM THERAPEUTICS
Primary Glioblastoma, Glioblastoma Multiforme
10/24
05/25
5G-RUBY, NCT06630260: Avutometinib and Defactinib in Malignant Brain Tumours

Recruiting
1/2
182
Europe
Avutometinib, VS-6766, Defactinib, Temozolomide, Temodal
Institute of Cancer Research, United Kingdom, Minderoo Foundation, Verastem, Inc., Royal Marsden NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust, Cancer Research UK, University of Cambridge
Glioblastoma Multiforme (GBM), Glioblastoma Multiform (Grade IV Astrocytoma), Diffuse Hemispheric Glioma, H3 G34-Mutant, Malignant Primary Gliomas
09/29
09/30
Benghiat, Helen
CLINGLIO, NCT04250922 / 2018-000365-37: LAM561 With RT and TMZ for Adults With Glioblastoma

Active, not recruiting
2/3
140
Europe, RoW
LAM561, TMZ, RT
Laminar Pharmaceuticals, Laboratory Corporation of America, Northern Institute for Cancer Research, Newcastle, Theradis pharma, LIPODOM THERAPEUTICS
Primary Glioblastoma, Glioblastoma Multiforme
10/24
05/25

Download Options